C-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells

被引:0
|
作者
MacEwen, EG
Kutzke, J
Carew, J
Pastor, J
Schmidt, JA
Tsan, R
Thamm, DH
Radinsky, R
机构
[1] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA
[2] Univ Wisconsin, Ctr Comprehens Canc, Madison, WI USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
关键词
c-Met; canine; human; osteosarcoma; hepatocyte growth factor; invasion; molecular determinants; scatter factor; urokinase plasminogen activator;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To further characterize the role of hepatocyte growth factor-scatter factor (HGF-SF) and its receptor (c-Met) in osteosarcoma (OS), human OS cell lines with low (SAOS-2) and high (SAOS-LM2) metastatic potential, and cell lines derived from spontaneous canine OS were studied. All cell lines were evaluated for c-Met and HGF-SF expression and receptor activation using Northern, RT-PCR, and Western blot analyses, respectively. Functional activity of receptor-ligand interaction was measured using c-Met phosphorylation status, proliferation assays (anchorage-dependent and - independent), Matrigel invasion, modulation of urokinase plasminogen activator (uPA) expression, and cell dispersion ( scattering). All cell lines exhibited steady-state mRNA expression of c-Met. The canine OS cell lines also expressed HGF-SF mRNA as determined by RT-PCR analysis. Western analysis showed c-Met protein expression and HGF-stimulated ( human) or constitutive ( canine) receptor autophosphorylation. Treatment with recombinant human HGF resulted in enhanced proliferation in 3 of 5 OS cell lines and enhanced colony formation in 2 of 5 OS cell lines. Matrigel invasion was significantly enhanced in 3 of the cell lines and uPA levels were significantly increased in the SAOS-2 cells following HGF treatment. Scattering was enhanced in both the SAOS-2 and SAOS-LM2 cells. These data support the involvement of c-Met and HGF-SF in the growth and progression of human and canine OS, and may offer new targets for the development of therapeutic strategies for OS.
引用
收藏
页码:421 / 430
页数:10
相关论文
共 50 条
  • [1] c-Met tyrosine kinase receptor expression and function in human and canine osteosarcoma cells
    E. Gregory MacEwen
    Jon Kutzke
    Jennifer Carew
    Josep Pastor
    Julie A. Schmidt
    Rachel Tsan
    Douglas H. Thamm
    Robert Radinsky
    Clinical & Experimental Metastasis, 2003, 20 (5) : 421 - 430
  • [2] Biological significance and targeting of c-Met tyrosine kinase receptor in cancer
    Goetsch, Liliane
    Caussanel, Veronique
    Corvaia, Nathalie
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2013, 18 : 454 - 473
  • [3] Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities
    Zhang, Yazhuo
    Xia, Mengfang
    Jin, Ke
    Wang, Shufei
    Wei, Hang
    Fan, Chunmei
    Wu, Yingfen
    Li, Xiaoling
    Li, Xiayu
    Li, Guiyuan
    Zeng, Zhaoyang
    Xiong, Wei
    MOLECULAR CANCER, 2018, 17
  • [4] Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma
    Akhavan-Sigari, R.
    Abili, M.
    Gaab, M. R.
    Rohde, V.
    Zafar, N.
    Emami, P.
    Ostertag, H.
    NEUROSURGICAL REVIEW, 2015, 38 (01) : 89 - 98
  • [5] ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
    Munshi, Neru
    Jeay, Sebastien
    Li, Youzhi
    Chen, Chang-Rung
    France, Dennis S.
    Ashwell, Mark A.
    Hill, Jason
    Moussa, Magdi M.
    Leggett, David S.
    Li, Chiang J.
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (06) : 1544 - 1553
  • [6] Molecular imaging of c-Met tyrosine kinase activity
    Zhang, Limin
    Virani, Shama
    Zhang, Yu
    Bhojani, Mahaveer S.
    Burgess, Teresa L.
    Coxon, Angela
    Galban, Craig J.
    Ross, Brian D.
    Rehemtulla, Alnawaz
    ANALYTICAL BIOCHEMISTRY, 2011, 412 (01) : 1 - 8
  • [7] Expression of constitutively active c-MET receptor in human choriocarcinoma
    Takayanagi, T
    Aoki, Y
    Tanaka, K
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 50 (03) : 198 - 202
  • [8] The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
    James W Welsh
    Daruka Mahadevan
    Ron Ellsworth
    Laurence Cooke
    David Bearss
    Baldassarre Stea
    Radiation Oncology, 4
  • [9] Expression of c-met tyrosine kinase receptor is biologically and prognostically relevant for primary cutaneous malignant melanomas
    Cruz, J
    Reis-Filho, JS
    Silva, P
    Lopes, JM
    ONCOLOGY, 2003, 65 (01) : 72 - 82
  • [10] Immunohistochemical expression of receptor tyrosine kinase PDGFR-α, c-Met, and EGFR in skull base chordoma
    R. Akhavan-Sigari
    M. Abili
    M. R. Gaab
    V. Rohde
    N. Zafar
    P. Emami
    H. Ostertag
    Neurosurgical Review, 2015, 38 : 89 - 99